Development of highly specific singleplex and multiplex real-time reverse transcription PCR assays for the identification of SARS-CoV-2 Omicron BA.1, BA.2 and Delta variants

Jeremy A. Garson, Samuel Badru, Anjna Badhan, Simon Dustan, Richard S. Tedder
doi: https://doi.org/10.1101/2022.04.07.22273168

Article Information

doi 
https://doi.org/10.1101/2022.04.07.22273168
History 
  • April 14, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Jeremy A. Garson1,*,
  2. Samuel Badru2,
  3. Anjna Badhan2,
  4. Simon Dustan2 and
  5. Richard S. Tedder3
  1. 1Division of Infection and Immunity, University College London, London, WC1E 6BT, UK
  2. 2Department of Infectious Disease, St. Mary’s Campus, Imperial College London, London, W2 1NY, UK
  3. 3Department of Microbiology, King’s College Hospital, Denmark Hill, London, SE5 9RS, UK
  1. ↵*Corresponding author E-mail: j.garson{at}ucl.ac.uk
Back to top
Posted April 14, 2022.
Download PDF
Data/Code
Email
Development of highly specific singleplex and multiplex real-time reverse transcription PCR assays for the identification of SARS-CoV-2 Omicron BA.1, BA.2 and Delta variants
Jeremy A. Garson, Samuel Badru, Anjna Badhan, Simon Dustan, Richard S. Tedder
medRxiv 2022.04.07.22273168; doi: https://doi.org/10.1101/2022.04.07.22273168
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area